 ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 31, 2022 GLOBE NEWSWIRE -- CRISPR Therapeutics Nasdaq: CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in September. 